Journal of the Formosan Medical Association
Volume 109, Issue 3 , Pages 192-200, March 2010

NEMO Gene Mutations in Chinese Patients With Incontinentia Pigmenti

  • Pa-Fan Hsiao

      Affiliations

    • Department of Dermatology, Mackay Memorial Hospital, Taipei, Taiwan
    • Mackay Medicine, Nursing and Management College, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Pa-Fan Hsiao, Department of Dermatology, Mackay Memorial Hospital, 92 Section 2, Chung-Shan North Road, Taipei 10449, Taiwan
    • ,
  • Shuan-Pei Lin

      Affiliations

    • Department of Pediatrics, Mackay Memorial Hospital, Taipei, Taiwan
    • Mackay Medicine, Nursing and Management College, Taipei, Taiwan
    • Department of Infant and Child Care, National Taipei College of Nursing, Taipei, Taiwan
    • ,
  • Shu-Shien Chiang

      Affiliations

    • Department of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan
    • ,
  • Yu-Hung Wu

      Affiliations

    • Department of Dermatology, Mackay Memorial Hospital, Taipei, Taiwan
    • Mackay Medicine, Nursing and Management College, Taipei, Taiwan
    • ,
  • Hsiu-Chin Chen

      Affiliations

    • Department of Dermatology, Mackay Memorial Hospital, Taipei, Taiwan
    • Taipei Medical University, Taipei, Taiwan
    • ,
  • Yang-Chih Lin

      Affiliations

    • Department of Dermatology, Mackay Memorial Hospital, Taipei, Taiwan
    • Mackay Medicine, Nursing and Management College, Taipei, Taiwan
    • Lee-Ming Institute of Technology, Taipei, Taiwan

Received 3 December 2008; received in revised form 26 March 2009; accepted 29 July 2009.

Article Outline

Background/Purpose

Incontinentia pigmenti is a rare, X-linked, dominant genodermatosis affecting skin, teeth, eyes, and central nervous system. Symptoms are associated with mutations in the nuclear factor-kappa B essential modulator (NEMO) gene on chromosome Xq28. Here, a subpopulation of Chinese patients with incontinentia pigmenti were examined to investigate the frequency and pattern of NEMO mutations, and to analyze their clinical features.

Methods

From January 1996 to August 2006, 52 participants (21 probands and 31 family members) were screened for symptoms of incontinentia pigmenti and NEMO gene mutations. We designed a NEMO-specific PCR primer, referred to as In2S, to detect a deletion of exon 4–10 of the NEMO gene, which represents the mutation most frequently associated with incontinentia pigmenti. For participants without this deletion, all exons were sequenced to screen for other NEMO mutations. In addition, the clinical manifestations and family histories of the participants were analyzed.

Results

Exon 4–10 was deleted in 13 probands, and one proband had a novel point mutation (G549C) in exon 5 that converted a glutamine to a histidine. Seven probands (33%) had no mutation in any of the exons of the NEMO gene. One of four participants who presented with hyperpigmentation also had the exon 4–10 deletion. One patient had a positive family history before the study took place, but no NEMO mutation was identified in any of the family members. Remarkably, the mothers of three of the probands exhibited the exon 4–10 deletion; however, their clinical manifestations were subtle and unrecognizable.

Conclusion

Mutational analysis of the NEMO gene was helpful in diagnosing incontinentia pigmenti among participants with a nearly normal phenotype or an incomplete form of the disease that only caused hyperpigmentation symptoms.

Key Words:  incontinentia pigmenti , NEMO gene

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Berlin AL , Paller AS , Chan LS . Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology . J Am Acad Dermatol . 2002;47:169–187
  2. Landy SJ , Donnai D . Incontinentia pigmenti (BlochSulzberger syndrome) . J Med Genet . 1993;30:53–59
  3. Smahi A , Courtois G , Vabres P , et al.   Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium . Nature . 2000;405:466–472
  4. Barkett M , Gilmore TD . Control of apoptosis by Rel/ NF-kappaB transcription factors . Oncogene . 1999;18:6910–6924
  5. Gerondakis S , Grossmann M , Nakamura Y , et al.   Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts . Oncogene . 1999;18:6888–6895
  6. Aradhya S , Woffendin H , Jakins T , et al.   A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations . Hum Mol Genet . 2001;10:2171–2179
  7. Fusco F , Bardaro T , Fimiani G , et al.   Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation . Hum Mol Genet . 2004;13:1763–1773
  8. Bardaro T , Falco G , Sparago A , et al.   Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/ IKKgamma gene deletion . Hum Mutat . 2003;21:8–11
  9. Steffann J , Raclin V , Smahi A , et al.   A novel PCR approach for prenatal detection of the common NEMO rearrangement in incontinentia pigmenti . Prenat Diagn . 2004;24:384–388
  10. Istrail S , Sutton GG , Florea L , et al.   Whole-genome shotgun assembly and comparison of human genome assemblies . Proc Natl Acad Sci USA . 2004;101:1916–1921
  11. Fusco F , Pescatore A , Bal E , et al.   Alterations of the IKBKG locus and diseases: an update and a report of 13 novel mutations . Hum Mutat . 2008;29:595–604
  12. Su PH , Chen JY , Yu JS , et al.   De novo incontinentia pigmenti in female twins . Acta Paediatr Taiwan . 2004;45:178–180
  13. Li L , Song GW , Du JB , et al.   NEMO Delta 4–10 deletion of NEMO gene in Chinese incontinentia pigmenti cases . Zhonghua Er Ke Za Zhi . 2005;43:89–92
  14. Chang JT , Chiu PC , Chen YY , et al.   Multiple clinical manifestations and diagnostic challenges of incontinentia pigmenti—12 years' experience in 1 medical center . J Chin Med Assoc . 2008;71:455–460
  15. Zhang G , Shi H , Du X , et al.   An incontinentia pigmenti family with deletion in both NEMO gene and pseudogene DeltaNEMO . Zhonghua Yi Xue Yi Chuan Xue Za Zhi . 2008;25:573–575
  16. Zhang XF , Li Y . A case report of incontinentia pigmenti . Zhongguo Dang Dai Er Ke Za Zhi . 2007;9:503–504
  17. Zou CC , Zhao ZY . Clinical and molecular analysis of NF-kappaB essential modulator in Chinese incontinentia pigmenti patients . Int J Dermatol . 2007;46:1017–1022
  18. Kim BJ , Shin HS , Won CH , et al.   Incontinentia pigmenti: clinical observation of 40 Korean cases . J Korean Med Sci . 2006;21:474–477
  19. Huang J , Kondo H , Uchio E . A case of incontinentia pigmenti in Japan and its genetic examination . Jpn J Ophthalmol . 2007;51:142–145
  20. Tada H , Yoshida S , Yamaji Y , et al.   NEMO mutational analysis in a Japanese family with incontinentia pigmenti . Eye . 2007;21:888–890
  21. Aradhya S , Courtois G , Rajkovic A , et al.   Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma) . Am J Hum Genet . 2001;68:765–771
  22. Martinez-Pomar N , Munoz-Saa I , Heine-Suner D , et al.   A new mutation in exon 7 of NEMO gene: late skewed X-chromosome inactivation in an incontinentia pigmenti female patient with immunodeficiency . Hum Genet . 2005;118:458–465
  23. Has C , Danescu S , Volz A , et al.   Incontinentia pigmenti in a newborn with a novel nonsense mutation in the NEMO gene . Br J Dermatol . 2007;156:392–393
  24. Phan TA , Wargon O , Turner AM . Incontinentia pigmenti case series: clinical spectrum of incontinentia pigmenti in 53 female patients and their relatives . Clin Exp Dermatol . 2005;30:474–480
  25. Schnur RE , Heymann WR . Reticulate hyperpigmentation . Semin Cutan Med Surg . 1997;16:72–80
  26. Mancini AJ , Lawley LP , Uzel G . X-linked ectodermal dysplasia with immunodeficiency caused by NEMO mutation: early recognition and diagnosis . Arch Dermatol . 2008;144:342–346

PII: S0929-6646(10)60042-3

doi:10.1016/S0929-6646(10)60042-3

Journal of the Formosan Medical Association
Volume 109, Issue 3 , Pages 192-200, March 2010

Article Tools